This document discusses drug delivery systems and controlled drug delivery. It defines drug delivery systems as formulations that deliver drugs in a site-directed or timely release manner. Controlled drug delivery can be achieved through spatial placement or temporal delivery of drugs. Ideal characteristics of controlled delivery systems include reducing drug toxicity, improving absorption and release profiles, and controlling drug release. The document discusses various approaches to controlled delivery such as delayed release, sustained release, and site-specific/receptor targeting systems. It also outlines factors to consider in drug and formulation selection for controlled delivery systems. Finally, it describes different mechanisms for controlled release including dissolution-controlled, diffusion-controlled, and combined dissolution-diffusion controlled systems.